STATE OF ARTEx situ heart perfusion: The past, the present, and the future
Section snippets
EVHP for preservation
Preserving heart with ex situ perfusion was first investigated in the 1960s, with both hypothermic24,25 and normothermic26 strategies. Since then, a number of teams across the world have developed EVHP machines. Encouragingly, despite the differences in machine designs and perfusion conditions, almost all studies arrived at the conclusion that EVHP is superior to SCS for heart preservation.
EVHP for assessment
Assessment of allograft function is a key advantage offered by ex situ machine perfusion. It is vital to understand which indices accurately predict donor heart quality, especially when EVHP is used to preserve extended-criteria allografts to combat donor organ shortage. Although the OCS offers the opportunity for cardiac viability evaluation, functional assessment of hearts in the non-working mode is not reliable,67,68 and the validity of perfusate lactate as a metabolic biomarker has been
EVHP for reconditioning
During EVHP, therapies can be delivered in high concentrations directly to donor hearts without concerns of being metabolized by other organs or exerting side effects on other body systems.83
From donation to implantation, donor hearts endure different forms of injuries at each stage. In DBD donors, excessive systemic and local catecholamine release84,85 leads to myocardial hypercontracture, band necrosis, and contractile dysfunction.86,87 After procurement, metabolic acidosis and inadequate ATP
Discussion
Whereas SCS is a reliable and time-tested preservation strategy, its limitations have been reached. Its deficiencies in extended-criteria DBD and DCD heart retrieval prevent the expansion of transplant activity. With decades of research experience, both HOP and NOP have been translated into clinical application with comparable or superior outcomes to that of SCS.
Both methods have their strengths and shortcomings (Table 4). NOP integrates preservation and functional assessment, which are
Disclosure statement
S.A. and J.H.D. have received, through their host institution, research grant funding in the form of an unrestricted educational grant from XVIVO Perfusion, Sweden. The remaining authors have no conflicts of interest to disclose.
The research was funded by the National Institute for Health Research Blood and Transplant Research Unit in Organ Donation and Transplantation at the University of Cambridge (Cambridge, United Kingdom) in collaboration with Newcastle University (Newcastle Upon Tyne,
Author contributions
All authors agree to be accountable for all aspects of the work and resolve any questions related to the accuracy of the manuscript and approved the final version of the manuscript.
Concept and design: L.W., S.A., J.H.D.
Drafting of the manuscript: L.W.
Critical revision of the manuscript for important intellectual content: L.W., G.A.M., S.A., J.H.D.
References (106)
- et al.
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report - 2019; focus theme: donor and recipient size match [published correction appears in J Heart Lung Transplant 2020;39:91]
J Heart Lung Transplant
(2019) - et al.
The Registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult heart transplantation report-2017; focus theme: allograft ischemic time
J Heart Lung Transplant
(2017) - et al.
Report from a consensus conference on primary graft dysfunction after cardiac transplantation
J Heart Lung Transplant
(2014) - et al.
The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database
J Thorac Cardiovasc Surg
(2007) - et al.
Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion
J Mol Cell Cardiol
(2011) - et al.
Isolated heart perfusion according to Langendorff—still viable in the new millennium
J Pharmacol Toxicol Methods
(2007) The Langendorff heart preparation—reappraisal of its role as a research and teaching model for coronary vasoactive drugs
J Pharmacol Methods
(1979)- et al.
Comparison of different techniques of hypothermic pig heart preservation
Ann Thorac Surg
(1994) - et al.
Low-flow hypothermic crystalloid perfusion is superior to cold storage during prolonged heart preservation
Transplant Proc
(2014) - et al.
Cardiac transplantation following storage of the donor heart by a portable hypothermic perfusion system
Ann Thorac Surg
(1984)
Twelve-hour reanimation of a human heart following donation after circulatory death
Heart Lung Circ
A novel combination technique of cold crystalloid perfusion but not cold storage facilitates transplantation of canine hearts donated after circulatory death
J Heart Lung Transplant
Forty-eight hours hypothermic perfusion storage of pig and baboon hearts
J Surg Res
Continuous perfusion of donor hearts in the beating state extends preservation time and improves recovery of function
J Thorac Cardiovasc Surg
A whole blood-based perfusate provides superior preservation of myocardial function during ex vivo heart perfusion
J Heart Lung Transplant
Normothermic ex vivo perfusion provides superior organ preservation and enables viability assessment of hearts from DCD donors
Am J Transplant
A cardioprotective preservation strategy employing ex vivo heart perfusion facilitates successful transplant of donor hearts after cardiocirculatory death
J Heart Lung Transplant
Increasing the tolerance of DCD hearts to warm ischemia by pharmacological postconditioning
Am J Transplant
Prospective multi-center European trial to evaluate the safety and performance of the Organ Care System for heart transplants (PROTECT)
J Heart Lung Transplant
294: Prospective multi-center safety and effectiveness evaluation of the Care System device for cardiac use (PROCEED)
J Heart Lung Transplant
Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial
Lancet
Outcome after warm machine perfusion (WMP) recovery of marginal brain dead (MBD) and donation after circulatory death (DCD) heart transplantation
J Heart Lung Transplant
LVAD bridging to heart transplantation with ex vivo allograft preservation shows significantly improved: outcomes: a new standard of care?
J Heart Lung Transplant
Evaluation of the Organ Care System in heart transplantation with an adverse donor/recipient profile
Ann Thorac Surg
Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series
Lancet
Outcomes of donation after circulatory death heart transplantation in Australia
J Am Coll Cardiol
Outcome after heart transplantation from donation after circulatory-determined death donors [published correction appears in J Heart Lung Transplant 2018;37:535]
J Heart Lung Transplant
Myocardial functional decline During prolonged ex situ heart perfusion
Ann Thorac Surg
Steroids limit myocardial edema during ex vivo perfusion of hearts donated after circulatory death
Ann Thorac Surg
Successful heart transplant after ten hours out-of-body time using the TransMedics organ Care System
Heart Lung Circ
Posttransplant function of a nonbeating heart is predictable by an ex vivo perfusion method
Ann Thorac Surg
The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion
J Heart Lung Transplant
241: The Organ Care System (OCS) enables ex-vivo assessment of donor heart coronary perfusion using contrast echocardiography
J Heart Lung Transplant
Chemical gating of gap junction channels; roles of calcium, pH and calmodulin
Biochim Biophys Acta
Physiologic changes in the heart following cessation of mechanical ventilation in a porcine model of donation after circulatory death: implications for cardiac transplantation
Am J Transplant
Both Na+-K+ ATPase and Na +-H+ exchanger are immediately active upon post-ischemic reperfusion in isolated rat hearts
J Mol Cell Cardiol
Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart
J Biol Chem
Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection
Int J Cardiol
Efficacy of MCI-186, a free-radical scavenger and antioxidant, for resuscitation of nonbeating donor hearts
J Thorac Cardiovasc Surg
Blockade of inflammation and apoptosis pathways by siRNA prolongs cold preservation time and protects donor hearts in a porcine model
Mol Ther Nucleic Acids
Hypothermic perfusion of donor heart with a preservation solution supplemented by mesenchymal stem cells
J Heart Lung Transplant
Preservation of the donor heart: from basic science to clinical studies
Interact Cardiovasc Thorac Surg
Oxygen consumption of the aerobically-perfused Cardioplegic donor heart at different temperatures
Ann Transplant
The critical role of bioenergetics in donor cardiac allograft preservation
J Cardiovasc Transl Res
Factors associated with primary graft failure after heart transplantation
Transplantation
The importance of cold and warm cardiac ischemia for survival after heart transplantation
Transplantation
Life-years gained by reducing donor heart ischemic times
Transplantation
Effects of older donor age and cold ischemic time on long-term outcomes of heart transplantation
Tex Heart Inst J
Myocardial reperfusion injury
N Engl J Med
Differential contribution of necrosis and apoptosis in myocardial ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol
Cited by (18)
Recipient Outcomes With Extended Criteria Donors Using Advanced Heart Preservation: An Analysis of the GUARDIAN-Heart Registry
2024, Journal of Heart and Lung TransplantationCon: The Use of an Organ Care System for Heart Transplant Has Led to Similar Outcomes with Expanded Donor Pools
2024, Journal of Cardiothoracic and Vascular AnesthesiaHeart transplantation
2023, Surgery (United Kingdom)Jacketed elastomeric tubes for passive self-regulation of pulsatile flow
2023, Journal of the Mechanical Behavior of Biomedical MaterialsEx-situ oxygenated hypothermic machine perfusion in donation after circulatory death heart transplantation following either direct procurement or in-situ normothermic regional perfusion
2023, Journal of Heart and Lung Transplantation